(XOM) Exxon Mobil - Overview
Stock: Crude Oil, Natural Gas, Fuels, Petrochemicals, Lubricants
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.62% |
| Yield on Cost 5y | 12.14% |
| Yield CAGR 5y | 3.47% |
| Payout Consistency | 51.7% |
| Payout Ratio | 57.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.4% |
| Relative Tail Risk | 3.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.45 |
| Alpha | 34.48 |
| Character TTM | |
|---|---|
| Beta | 0.512 |
| Beta Downside | 0.909 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.92% |
| CAGR/Max DD | 0.65 |
Description: XOM Exxon Mobil January 26, 2026
Exxon Mobil (XOM) is an integrated oil-and-gas company that extracts crude oil and natural gas across North America, the Caribbean (Guyana), Europe, and Asia, and then refines, markets, and manufactures a broad portfolio of energy and specialty products-including fuels, petrochemicals, lubricants, and low-emission solutions such as carbon-capture, hydrogen, and sustainable aviation fuel-under the Exxon, Esso, and Mobil brands.
In Q2 2024, Exxon Mobil reported adjusted earnings of $2.86 billion, a 12 % year-over-year increase, driven by an average realized crude price of $84 per barrel and upstream production of 3.9 million boe/d (up 3 % YoY). Free cash flow reached $7.4 billion, supporting a 2024 dividend of $1.24 per share (yield ≈ 5.7 %). Capital expenditures were $6.1 billion, with $2.3 billion allocated to lower-emission projects, reflecting sector pressure to decarbonize and the $100 billion-scale investment horizon for carbon-capture and hydrogen. The broader integrated-oil sector remains sensitive to global oil demand forecasts (IEA’s 2024 demand growth of 1.2 % / yr) and to regulatory shifts that could affect the economics of low-carbon fuels.
For a deeper, data-driven view of how these trends translate into valuation signals, you may find ValueRay’s analyst tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 28.84b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.51 > 1.0 |
| NWC/Revenue: 3.41% < 20% (prev 6.39%; Δ -2.98% < -1%) |
| CFO/TA 0.12 > 3% & CFO 51.97b > Net Income 28.84b |
| Net Debt (59.58b) to EBITDA (67.86b): 0.88 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.24b) vs 12m ago -5.02% < -2% |
| Gross Margin: 21.68% > 18% (prev 0.23%; Δ 2146 % > 0.5%) |
| Asset Turnover: 71.78% > 50% (prev 74.81%; Δ -3.03% > 0%) |
| Interest Coverage Ratio: 69.44 > 6 (EBITDA TTM 67.86b / Interest Expense TTM 603.0m) |
Altman Z'' 7.27
| A: 0.02 (Total Current Assets 83.38b - Total Current Liabilities 72.33b) / Total Assets 448.98b |
| B: 1.07 (Retained Earnings 482.49b / Total Assets 448.98b) |
| C: 0.09 (EBIT TTM 41.87b / Avg Total Assets 451.23b) |
| D: 2.84 (Book Value of Equity 517.78b / Total Liabilities 182.35b) |
| Altman-Z'' Score: 7.27 = AAA |
Beneish M -3.02
| DSRI: 1.07 (Receivables 44.56b/43.68b, Revenue 323.90b/339.25b) |
| GMI: 1.04 (GM 21.68% / 22.62%) |
| AQI: 1.00 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.95 (Revenue 323.90b / 339.25b) |
| TATA: -0.05 (NI 28.84b - CFO 51.97b) / TA 448.98b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of XOM shares?
Over the past week, the price has changed by +9.26%, over one month by +21.35%, over three months by +29.02% and over the past year by +41.26%.
Is XOM a buy, sell or hold?
- StrongBuy: 10
- Buy: 7
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the XOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 140.6 | -7% |
| Analysts Target Price | 140.6 | -7% |
| ValueRay Target Price | 179.7 | 18.8% |
XOM Fundamental Data Overview February 07, 2026
P/E Forward = 20.0401
P/S = 1.9019
P/B = 2.3778
P/EG = 1.9266
Revenue TTM = 323.90b USD
EBIT TTM = 41.87b USD
EBITDA TTM = 67.86b USD
Long Term Debt = 34.24b USD (from longTermDebt, last quarter)
Short Term Debt = 9.30b USD (from shortTermDebt, last quarter)
Debt = 70.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 59.58b USD (from netDebt column, last quarter)
Enterprise Value = 675.62b USD (616.04b + Debt 70.26b - CCE 10.68b)
Interest Coverage Ratio = 69.44 (Ebit TTM 41.87b / Interest Expense TTM 603.0m)
EV/FCF = 28.61x (Enterprise Value 675.62b / FCF TTM 23.61b)
FCF Yield = 3.49% (FCF TTM 23.61b / Enterprise Value 675.62b)
FCF Margin = 7.29% (FCF TTM 23.61b / Revenue TTM 323.90b)
Net Margin = 8.91% (Net Income TTM 28.84b / Revenue TTM 323.90b)
Gross Margin = 21.68% ((Revenue TTM 323.90b - Cost of Revenue TTM 253.67b) / Revenue TTM)
Gross Margin QoQ = 18.89% (prev 22.42%)
Tobins Q-Ratio = 1.50 (Enterprise Value 675.62b / Total Assets 448.98b)
Interest Expense / Debt = -0.11% (Interest Expense -80.0m / Debt 70.26b)
Taxrate = 17.71% (1.42b / 8.03b)
NOPAT = 34.46b (EBIT 41.87b * (1 - 17.71%))
Current Ratio = 1.15 (Total Current Assets 83.38b / Total Current Liabilities 72.33b)
Debt / Equity = 0.27 (Debt 70.26b / totalStockholderEquity, last quarter 259.39b)
Debt / EBITDA = 0.88 (Net Debt 59.58b / EBITDA 67.86b)
Debt / FCF = 2.52 (Net Debt 59.58b / FCF TTM 23.61b)
Total Stockholder Equity = 261.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.39% (Net Income 28.84b / Total Assets 448.98b)
RoE = 11.04% (Net Income TTM 28.84b / Total Stockholder Equity 261.31b)
RoCE = 14.17% (EBIT 41.87b / Capital Employed (Equity 261.31b + L.T.Debt 34.24b))
RoIC = 11.43% (NOPAT 34.46b / Invested Capital 301.48b)
WACC = 6.99% (E(616.04b)/V(686.30b) * Re(7.80%) + D(70.26b)/V(686.30b) * Rd(-0.11%) * (1-Tc(0.18)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 2.80%
[DCF Debug] Terminal Value 79.65% ; FCFF base≈26.45b ; Y1≈22.47b ; Y5≈17.17b
Fair Price DCF = 78.27 (EV 386.65b - Net Debt 59.58b = Equity 327.08b / Shares 4.18b; r=6.99% [WACC]; 5y FCF grow -18.25% → 2.90% )
EPS Correlation: -79.51 | EPS CAGR: -4.97% | SUE: 0.23 | # QB: 0
Revenue Correlation: -65.34 | Revenue CAGR: -2.42% | SUE: -0.63 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.49 | Chg30d=-0.155 | Revisions Net=-2 | Analysts=16
EPS current Year (2026-12-31): EPS=6.95 | Chg30d=-0.059 | Revisions Net=-2 | Growth EPS=-0.6% | Growth Revenue=-3.1%
EPS next Year (2027-12-31): EPS=8.34 | Chg30d=-0.077 | Revisions Net=-2 | Growth EPS=+20.1% | Growth Revenue=+9.7%